Research field (2):
Ophthalmology
, Pathobiochemistry
Research keywords (6):
Pharmaceuticals and Medical Devices Development
, Real-time imaging
, Retinal neuroprotective therapy
, Filtration surgery
, Retinal diseases
, Glaucoma
Research theme for competitive and other funds (6):
2024 - 2027 ヒト緑内障GWASからの個別化創薬プラットフォーム構築研究
2021 - 2024 瘢痕化定量技術と薬剤ナノ粒子化による組織移行性の高い濾過胞瘢痕抑制薬の開発
2021 - 2024 前眼部組織間のトランスオミクス解析による包括的な眼圧上昇機序の解明
2019 - 2021 Establishment of novel biomarkers and drug discovery bases for the development of filter bleb scarring inhibitors
2020 - 2021 活性イオウ分子種を用いた新規抗酸化眼内灌流液の開発
2017 - 2019 Role of transcription factor Sp1 in retinal ganglion cell death in mouse glaucoma model animals
Show all
Papers (143):
Satoru Tsuda, Hiroshi Kunikata, Makoto Ishikawa, Airi Takagi, Takeshi Yabana, Mitsuru Suzuki, Mitsuru Sugawara, Seiji Morino, Toru Nakazawa. Detection of Glaucomatous Visual Fields Using a Newly Developed Device with Retinal Projection Technology. The Tohoku journal of experimental medicine. 2025
Parmanand Sharma, Naoki Takahashi, Takahiro Ninomiya, Masataka Sato, Takehiro Miya, Satoru Tsuda, Toru Nakazawa. A hybrid multi model artificial intelligence approach for glaucoma screening using fundus images. NPJ digital medicine. 2025. 8. 1. 130-130